Transparent electrodes based on graphene are ideal for multimodal cell sensing. However, the atomically flat basal plane of graphene limits the applications largely to capacitive detection of extracellular signals. Here, we develop a biocompatible graphene-carbon nanotube (CNT) hybrid (Bio-GCH), consisting of a graphene substrate covalently decorated with sparsely distributed CNT structures. Bio-GCH electrodes enable low-bias (~4 V) nano-electroporation of cardiomyocytes and high-quality intracellular recordings, with CNTs serving as the dominant electrical transduction channel. At the same time, Bio-GCH electrodes retain the key advantages of graphene electrodes, including high optical transparency, electrical mobility, electrochemical stability, and biocompatibility.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: